Acadia Healthcare (NASDAQ:ACHC) Shares Gap Up – Time to Buy?

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) gapped up before the market opened on Wednesday . The stock had previously closed at $24.42, but opened at $25.51. Acadia Healthcare shares last traded at $25.43, with a volume of 249,287 shares traded.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ACHC. KeyCorp reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Acadia Healthcare in a research report on Wednesday, May 27th. Cantor Fitzgerald increased their price target on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Guggenheim upped their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus target price of $26.85.

Acadia Healthcare Trading Up 4.8%

The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.35 billion, a P/E ratio of -2.09, a PEG ratio of 7.84 and a beta of 0.69. The firm’s 50-day simple moving average is $25.22 and its 200 day simple moving average is $19.47.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.49 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Acadia Healthcare during the first quarter worth $1,600,000. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after purchasing an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares during the period. American Century Companies Inc. lifted its stake in Acadia Healthcare by 531.5% during the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after buying an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. boosted its holdings in shares of Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after buying an additional 1,780 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.